Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: Less can be more, more or less

Addiction

Volumn 107, Issue 9, 2012, Pages 1650-1659

  Carroll, Kathleen M ^a   Nich, Charla ^a   Lapaglia, Donna M ^a   Peters, Erica N ^a   Easton, Caroline J ^a   Petry, Nancy M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cannabis dependence; Cognitive behavioral therapy; Contingency management; Criminal justice system; Randomized clinical trial

Indexed keywords

ADULT; AMBULATORY CARE; ANALYSIS OF VARIANCE; ARTICLE; CANNABIS ADDICTION; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REWARD; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANALYSIS OF VARIANCE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARIJUANA ABUSE; PATIENT COMPLIANCE; REWARD; TREATMENT OUTCOME;

EID: 84864743924     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03877.x     Document Type: Article

References (60)

1. Levin F. R., Mariani J. J., Brooks D. J., Pavlicova M., Cheng W., Nunes E. V. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 2011; 116: 142-50.
2. Vandrey R., Haney M. Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs 2009; 23: 543-53.
3. Budney A. J., Roffman R., Stephens R. S., Walker D. Marijuana dependence and its treatment. Addict Sci Clin Pract 2007; 4: 4-16.
4. Denis C., Lavie E., Fatseas M., Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Syst Rev 2006; 3, CD005336.
5. Carroll K. M., Easton C. J., Nich C., Hunkele K. A., Neavins T. M., Sinha R. etal. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol 2006; 74: 955-66. PMCID: PMC2148500.
6. Kadden R. M., Litt M. D., Kabela-Cormier E., Petry N. M. Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav 2007; 32: 1220-36.
7. Carroll K. M. Combined treatments for substance dependence. In: Sammons M. T., Schmidt N. B., editors. Combined Treatments for Mental Disorders: Pharmacological and Psychotherapeutic Strategies for Intervention. Washington, DC: American Psychological Assosciation Press; 2001, p. 215-38.
8. DeRubeis R. J., Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J Consult Clin Psychol 1998; 66: 37-52.
9. Carroll K. M. Relapse prevention as a psychosocial treatment approach: a review of controlled clinical trials. Exp Clin Psychopharmacol 1996; 4: 46-54.
10. Irvin J. E., Bowers C. A., Dunn M. E., Wong M. C. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999; 67: 563-70.
11. National Institutes on Drug Abuse (NIDA). Principles of Drug Addiction Treatment: A Research-Based Guide. Bethesda, MD: NIDA; 2000.
12. Dutra L., Stathopoulou G., Basden S. L., Leyro T. M., Powers M. B., Otto M. W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 179-87.
13. Carroll K. M., Rounsaville B. J., Nich C., Gordon L. T., Wirtz P. W., Gawin F. H. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51: 989-97.
14. Carroll K. M., Nich C., Ball S. A., McCance-Katz E. F., Frankforter T. F., Rounsaville B. J. One year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: sustained effects of treatment. Addiction 2000; 95: 1335-49.
15. O'Malley S. S., Jaffe A. J., Chang G., Rode S., Schottenfeld R., Meyer R. E. etal. Six month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996; 53: 217-24.
16. Blagys M. D., Hilsenroth M. J. Distinctive activities of cognitive behavioral therapy: a review of the comparative psychotherapy process literature. Clin Psychol Rev 2002; 22: 671-706.
17. Burns D. D., Spangler D. L. Does psychotherapy homework lead to improvements in depression in cognitive-behavioral therapy or does improvement lead to increased homework compliance? J Consult Clin Psychol 2000; 68: 46-56.
18. Hollon S. D. Does cognitive therapy have an enduring effect? Cogn Ther Res 2003; 27: 71-5.
19. Carroll K. M., Nich C., Frankforter T. L., Bisighini R. M. Do patients change in the way we intend? Treatment-specific skill acquisition in cocaine-dependent patients using the Cocaine Risk Response Test. Psychol Assess 1999; 11: 77-85.
20. Brown T. G., Seraganian P., Tremblay J., Annis H. M. Process and outcome changes with relapse prevention versus 12-Step aftercare programs for substance abusers. Addiction 2002; 97: 677-89.
21. Griffith J. D., Rowan-Szal G. A., Roark R. R., Simpson D. D. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend 2000; 58: 55-66.
22. Petry N. M. A comprehensive guide to the application of contigency management procedures in clinical settings. Drug Alcohol Depend 2000; 58: 9-25.
23. Higgins S. T., Silverman K. Motivating Behavior Change Among Illicit-Drug Abusers. Washington, DC: American Psychological Association; 1999.
24. Petry N. M., Petrakis I., Trevisan L., Wiredu L., Boutros N., Martin B. etal. Contingency management interventions: from research to practice. Am J Psychiatry 2001; 20: 33-44.
25. Carroll K. M., Ball S. A., Nich C., O'Connor P. G., Eagan D., Frankforter T. L. etal. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry 2001; 58: 755-61.
26. Carroll K. M., Sinha R., Nich C., Babuscio T., Rounsaville B. J. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol 2002; 10: 54-63.
27. Preston K. L., Silverman K., Umbricht A., DeJesus A., Montoya I. D., Schuster C. R. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 1999; 54: 127-35.
28. Crowley T. J. Research on contingency management treatment of drug dependence: clinical implications and future directions. In: Higgins S. T., Silverman K., editors. Motivating Behavior Change Among Illicit Drug Abusers. Washington, DC: American Psychological Association; 1999, p. 345-70.
29. Silverman K., Higgins S. T., Brooner R. K., Montoya I. D., Cone E. J., Schuster C. R. etal. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996; 53: 409-15.
30. Marlatt G. A. Integrating contingency management with relapse prevention skills training: comment on Silverman etal. (2001). Exp Clin Psychopharmacol 2001; 9: 33-4.
31. MTP Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol 2004; 72: 455-66.
32. Wei L. J., Lachin J. M. Properties of the urn randomization in clinical trials. Control Clin Trials 1988; 9: 345-64.
33. Stout R. L., Wirtz P. W., Carbonari J. P., DelBoca F. K. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl 1994; 12: 70-5.
34. Carroll K. M., Nich C., Sifry R., Frankforter T. L., Nuro K. F., Ball S. A. etal. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend 2000; 57: 225-38.
35. Carroll K. M., Connors G. J., Cooney N. L., DiClemente C. C., Donovan D. M., Longabaugh R. L. etal. Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol 1998; 66: 290-303.
36. Steinberg K., Roffman R. A., Carroll K. M., McRee B., Babor T. F., Miller M. etal. Brief Counseling for Marijuana Dependence: A Manual for Treating Adults. Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 2005.
37. Petry N. M., Martin B., Cooney J. L., Kranzler H. R. Give them prizes and they will come: contingency management treatment of alcohol dependence. J Consult Clin Psychol 2000; 68: 250-7.
38. Petry N. M., Alessi S. M., Marx J., Austin M., Tardiff M. Vouchers versus prizes: contingency management of treatment of substance abusers in community settings. J Consult Clin Psychol 2005; 73: 1005-14.
39. Higgins S. T., Sigmon S. C., Wong C. J., Heil S. H., Badger G. L., Donham R. etal. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry 2003; 60: 1043-52.
40. Petry N. M., Roll J. M., Rounsaville B. J., Ball S. A., Stitzer M., Peirce J. M. etal. Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol 2008; 76: 1076-82. PMCID: PMC2756150.
41. Gibbons C. J., Nich C., Steinberg K., Roffman R. A., Corvino J., Babor T. F. etal. Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction 2010; 105: 1799-808.
42. Martino S., Ball S. A., Nich C., Frankforter T. L., Carroll K. M. Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend 2008; 97: 37-48. PMCID: PMC2692429.
43. Martino S., Ball S. A., Nich C., Frankforter T. L., Carroll K. M. Informal discussions in substance abuse treatment sessions. J Subst Abuse Treat 2009; 36: 366-75. PMCID: PMC2705985.
44. Martino S., Ball S. A., Nich C., Canning-Ball M., Rounsaville B. J., Carroll K. M. Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies. Addiction 2011; 106: 428-41.
45. Shrout P. E., Fleiss J. L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-9.
46. Miller W. R., DelBoca F. K. Measurement of drinking behavior using the Form 90 family of instruments. J Stud Alcohol Suppl 1994; 12: 112-17.
47. Sobell L. C., Sobell M. B. Timeline followback: a technique for assessing self-reported alcohol consumption. In: Litten R. Z., Allen J., editors. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992, p. 41-72.
48. Fals-Stewart W., O'Farrell T. J., Freitas T. T., McFarlin S. K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000; 68: 134-44.
49. Babor T. F., Steinberg K., Anton R. F., Del Boca F. K. Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol 2000; 61: 55-63.
50. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. Structured Clinical Interview for DSM-IV, Patient Edition. Washington, DC: American Psychiatric Press; 1995.
51. Carroll K. M., Ball S. A., Nich C., Martino S., Frankforter T. L., Crits-Christoph P. etal. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend 2006; 81: 301-12. PMCID: PMC2386852.
52. Budney A. J., Higgins S. T., Radonovich K. J., Novy P. L. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000; 68: 1051-61.
53. Gibbons R. D., Hedeker D., Elkin I., Waternaux C., Kraemer H. C., Greenhouse J. B. etal. Some conceptual and statistical issues in analyses of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50: 739-50.
54. Singer J. D., Willett J. B. Applying Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003.
55. Ball S. A., Martino S., Nich C., Frankforter T. L., Van Horn D., Crits-Christoph P. etal. Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol 2007; 75: 556-67. PMCID: PMC2148493.
56. Budney A. J., Moore B. A., Rocha H. L., Higgins S. T. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol 2006; 74: 307-16.
57. Deci F. L., Koestner R., Ryan R. M. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull 1999; 128: 627-68.
58. Messina N., Farabee D., Rawson R. A. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions. J Consult Clin Psychol 2003; 71: 320-9.
59. Peters E. N., Nich C., Carroll K. M. Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. Drug Alcohol Depend 2011; 118: 408-16.
60. Donovan D. M., Bigelow G. E., Brigham G. S., Carroll K. M., Cohen A. J., Gardin J. G. etal. Primary outcomes indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use endpoints in clinical trials. Addiction 107: 694-708.